Latest News

News
Davaindia Unveils E-Commerce Platform in Pune, Marking a Bold Step Toward Affordable and Accessible Healthcare Delivery
15-04-2025
News
Apollo Hospitals Eyes Expansion via Acquisitions and Greenfield Projects to Strengthen Market Leadership in India's Evolving Healthcare Landscape
15-04-2025
News
Delhi's Healthcare Landscape Set for Major Overhaul with Launch of 70 Ayushman Arogya Mandirs and Phasing Out of Rented Mohalla Clinics
15-04-2025
News
AI Revolutionizes Tuberculosis Detection Across Diverse Healthcare Settings- KIMS and POCUS
15-04-2025
News
International Diabetes Federation Designates "Type 5 Diabetes" to Address Malnutrition-Related Form of Disease
15-04-2025
Article
Minimally Invasive Spine Surgery: A Game Changer for Faster Recovery
12-04-2025
Corporate Update

Sun Pharma hits record high By eHealth Network - 04 July 2014

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent.

Sun Pharma stock surged 2 percent to Rs 707, while Ranbaxy Laboratories gained 2 percent to Rs 534.


USFDA has granted approval to Ranbaxy’s subsidiary Ohm Laboratories to manufacture and sell generic Diovan in the US.

Source: IIFL



Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!

Tags: BSE Sensex Business/Finance Diovan Economy of India food and drug administration Health/Medical/Pharmaceuticals India Infoline OHM LABORATORIES INC. Pharmaceutical industry Pharmaceutical sciences Pharmacology Ranbaxy Laboratories RANBAXY LABORATORIES LTD Sun Pharma Sun Pharmaceutical SUN PHARMACEUTICAL INDUSTRIES LIMITED Technology/Internet United States

Related Corporate Updates

whatsapp--v1 JOIN US
whatsapp--v1